Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-25 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.110 | -0.100 | 0.0100 | ||||
REV | 20.160M | 20.528M | 368.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
GTH | Genetron Holdings | 22.77 | 2.25 | 10.96% | 2B |
You can purchase shares of Genetron Holdings (NASDAQ: GTH) through any online brokerage.
Other companies in Genetron Holdings’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), ADC Therapeutics (NYSE:ADCT) and FibroGen (NASDAQ:FGEN).
The latest price target for Genetron Holdings (NASDAQ: GTH) was reported by BTIG on 2020-07-14. The analyst firm set a price target for 20.00 expecting GTH to fall to within 12 months (a possible -12.17% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Genetron Holdings (NASDAQ: GTH) is $22.77 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Genetron Holdings.
There is no upcoming split for Genetron Holdings.